Document is current
Any future updates will be listed below
-
Authors
François, Liesbeth https://orcid.org/0000-0001-6346-8303
Romagnolo, Alessia https://orcid.org/0000-0001-5357-0961
Luinenburg, Mark J. https://orcid.org/0000-0002-9097-8090
Anink, Jasper J.
Godard, Patrice
Rajman, Marek
van Eyll, Jonathan https://orcid.org/0000-0002-9949-0526
Mühlebner, Angelika
Skelton, Andrew
Mills, James D.
Dedeurwaerdere, Stefanie
Aronica, Eleonora https://orcid.org/0000-0002-3542-3770
- License Information
-
More Information
Article History
Received: 1 June 2023
Accepted: 1 March 2024
First Online: 11 March 2024
Competing interests
: A.R., E.A., and J.D.M. received an unrestricted grant from UCB Pharma. L.F., P.G., A.S., M.R., J.v. E., and S.D. are employees of UCB Pharma, and P.G., J.v. E., A.S., and S.D. receive stock or stock options from their employment. The remaining authors declare no competing interests.
